2022
Placing Leishmaniasis in the Limelight through the Communicable Disease Surveillance System: An Experience from Sri Lanka
Gunasekara SD, Nuwangi H, Wickramasinghe ND, Weerakoon K, Price HP, Dikomitis L, Agampodi SB. Placing Leishmaniasis in the Limelight through the Communicable Disease Surveillance System: An Experience from Sri Lanka. Pathogens 2022, 11: 680. PMID: 35745534, PMCID: PMC9227132, DOI: 10.3390/pathogens11060680.Peer-Reviewed Original ResearchThe effect of incarceration on TB treatment outcomes
O Marr J, Gonçalves C, Arakaki-Sanchez D, Pelissari D, Costa F, Croda J, Walter K, Andrews J. The effect of incarceration on TB treatment outcomes. The International Journal Of Tuberculosis And Lung Disease 2022, 26: 252-258. PMID: 35197165, DOI: 10.5588/ijtld.21.0449.Peer-Reviewed Original ResearchConceptsNon-incarcerated individualsTreatment successTreatment outcomesDrug-susceptible TB casesImproved treatment successTB treatment outcomesTB treatment successClinical risk factorsIncarcerated individualsMultivariate logistic regressionGreater treatment successTB casesClinical factorsObserved therapyPoor outcomeTB notificationsRisk factorsElevated riskGreater efficacyLogistic regressionNotifiable diseaseOutcomesIncarcerated populationsVulnerable individualsUse of DOT
2020
Is leishmaniasis adequately notified in Sri Lanka? A survey among doctors from an endemic district, Sri Lanka
Hewawasam C, Weerakoon HS, Thilakan V, Lelwala T, Prasanka K, Rathnayaka AS, Gamage S, Agampodi S. Is leishmaniasis adequately notified in Sri Lanka? A survey among doctors from an endemic district, Sri Lanka. BMC Public Health 2020, 20: 913. PMID: 32532244, PMCID: PMC7290071, DOI: 10.1186/s12889-020-09066-w.Peer-Reviewed Original ResearchConceptsMedical officersMethodsA cross-sectional studyFirst clinical suspicionHigh disease burdenCross-sectional studyHigh case loadSelf-administered questionnaireHealth Care InstituteAnuradhapura districtCurrent notification systemClinical suspicionResultsOne hundredDisease burdenCare instituteCausative organismEarly diagnosisEndemic districtsCutaneous leishmaniasisParasitic infectionsLeishmaniasisNotifiable diseaseCase loadLeishmania donovaniDiseaseSupportive staff
1999
Hidden Mortality Attributable to Rocky Mountain Spotted Fever: Immunohistochemical Detection of Fatal, Serologically Unconfirmed Disease
Paddock C, Greer P, Ferebee T, Singleton J, McKechnie D, Treadwell T, Krebs J, Clarke M, Holman R, Olson J, Childs J, Zaki S. Hidden Mortality Attributable to Rocky Mountain Spotted Fever: Immunohistochemical Detection of Fatal, Serologically Unconfirmed Disease. The Journal Of Infectious Diseases 1999, 179: 1469-1476. PMID: 10228069, DOI: 10.1086/314776.Peer-Reviewed Original ResearchConceptsCase fatality ratioDiagnosis of RMSFIHC stainingRocky Mountain Spotted FeverLaboratory-confirmed casesAcute-phase seraTickborne infectionHidden mortalityIgM antibodiesDiagnostic titerPolymerase chain reactionIHC findingsPatient seraSerologic assaysImmunohistochemical stainingSpotted FeverImmunohistochemical detectionFatal diseasePatientsDisease controlIndirect immunofluorescenceNotifiable diseaseDiseaseUnderestimates of mortalityTissue samples
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply